Provided by Tiger Trade Technology Pte. Ltd.

Immuneering Corp

4.65
+0.04000.87%
Volume:296.31K
Turnover:1.36M
Market Cap:300.25M
PE:-4.75
High:4.69
Open:4.53
Low:4.48
Close:4.61
52wk High:10.08
52wk Low:3.86
Shares:64.57M
Float Shares:49.21M
Volume Ratio:0.95
T/O Rate:0.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9796
EPS(LYR):-1.2729
ROE:-52.15%
ROA:-32.77%
PB:1.57
PE(LYR):-3.65

Loading ...

Immuneering Corp - Ends Q1 2026 With $198.6 Mln in Cash and Securities; Runway Into 2029

THOMSON REUTERS
·
May 15

Immuneering Corporation Q1 Net Income USD -13.5 Million VS. Ibes Estimate USD -17.3 Million

THOMSON REUTERS
·
May 15

Press Release: Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates

Dow Jones
·
May 15

Immuneering’s Phase 3 Pancreatic Cancer Trial Puts Atebimetinib in the Spotlight for IMRX Investors

TIPRANKS
·
May 08

Immuneering announces updated data from Phase 2a trial for atebimetinib

TIPRANKS
·
Apr 22

Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting

GlobeNewswire
·
Apr 22

Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX) and McKesson (MCK)

TIPRANKS
·
Apr 21

Immuneering announces annual shareholder meeting webcast

Reuters
·
Apr 21

Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond

GlobeNewswire
·
Apr 20

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Immuneering (IMRX) and Maze Therapeutics, Inc. (MAZE)

TIPRANKS
·
Apr 14

Immuneering CEO to join Needham Virtual Healthcare Conference fireside chat

Reuters
·
Apr 07

Immuneering to present atebimetinib ctDNA analysis at AACR Annual Meeting

Reuters
·
Mar 18

Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival

GlobeNewswire
·
Mar 18